Previous
Previous

EpiBiologics Appoints Ann Lee-Karlon as Chief Executive Officer and President, Extends Series A Financing to Over $70 Million

Next
Next

EpiBiologics Launches with $50 million Series A Financing to Advance Next-Generation Protein Degradation Platform